Sanara MedTech Q1 revenue rises, swings to profit

Sanara MedTech

11/05/2026 22:01

Overview

U.S. surgical medtech firm's Q1 revenue rose 19% year-over-year

Company posted net profit from continuing operations, reversing prior-year loss

Adjusted EBITDA rose 58% year-over-year, driven by revenue growth and higher sales expenses

Outlook

Sanara MedTech expects Q2 net revenue between $28.5 mln and $29.5 mln

Company reaffirms 2026 full-year net revenue guidance of $116 mln to $121 mln

Sanara MedTech says strengthened sales team and surgical focus expected to drive results

Result Drivers

SOFT TISSUE PRODUCT SALES - Revenue growth was primarily driven by a 21% increase in sales of soft tissue repair products, attributed to increased market penetration and geographic expansion

SALES FORCE EXPANSION - Company expanded its sales team to 43 representatives to support revenue growth and focus on the surgical setting

INCREASED FACILITY AND DISTRIBUTOR REACH - Products were contracted or approved in over 4,000 hospitals and ambulatory surgery centers, sold in over 1,400 facilities, and distributed through more than 450 distributors

Company press release: ID:nGNX84nXms

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
$27.80 mln
$26.80 mln (2 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the pharmaceuticals peer group is "buy"

Wall Street's median 12-month price target for Sanara Medtech Inc is $34.00, about 84.8% above its May 8 closing price of $18.40

The stock recently traded at 59 times the next 12-month earnings vs. a P/E of 34 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)